Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

18 Apr 2007 07:01

ViaLogy PLC18 April 2007 Date: 18 April 2007 On behalf of: ViaLogy plc ("ViaLogy" or "the Company") For Immediate Release ViaLogy PLC Board Appointment LONDON, April 18, 2007 -- ViaLogy PLC (LSE: VIY), the AIM-quoted technologycompany, today announced the appointment of Mr. Shah Talukder as executivedirector of ViaLogy with immediate effect. In addition to his appointment tothe main Board, Mr Talukder has also been appointed President and ChiefExecutive Officer of ViaLogy's wholly-owned American subsidiary, ViaLogy LLC, ofPasadena, California. Mr. Talukder comes to ViaLogy from Cisco Systems, where he was General Managerof Cisco's Safety, Security and Systems Business Unit (S3BU) where heestablished a start-up culture. Within Cisco he developed the vision,strategy, and road map for the Interoperability and Collaboration System (IPICS)family of products and applications. The system enables personnel within thesame or different agencies to communicate across previously isolated radio, IPand non-IP networks by delivering information to various types of communicationsdevices. These could range from a radio, a telephone, and an IP phone to amobile phone and a computer. At Cisco, Mr. Talukder was also instrumental in working closely with customers,industry and technology leaders, research institutions and sensor vendors todefine a vision and strategy for the Sensor Policy Manager (SPM) as a frameworkfor sensor based rapid detection and response to greatly improve the quality andspeed of information dissemination. "I am very excited at the potential of ViaLogy and I am looking forward toleading and growing the team," said Mr. Talukder. "The breadth of technologiesdeveloped by the company is extremely impressive and has a wide range ofapplications. It has the potential to become a platform for sensor and networksub-system interoperability and provide a service delivery architecture based oncustomer specific needs in such areas as Enterprise Security and Operations,Defence, Connected Real Estate, Oil and Gas, Transportation, Home Land Security,Retail and Healthcare." Mr Talukder added: "Customers and industry at large are looking for scaleablesolutions to sensor based remote monitoring, emissions mitigation, greenenvironment, physical and border security. As an example customers globally,regardless of national boundaries, whom I have met and spoken to are keenlyinterested in enhancing their capabilities to remotely monitor and respond togreenhouse gas, seismic and motion sensors, biological agents or to detectpressure in oil or gas pipelines. They want to provide the appropriateinformation within seconds, based on policy and business rules governing theincident. The information could be send to specific PC laptops, cell phones,PDAs, IP Phones, TV or digital signage etc. and could be in the form ofstandards-based video, voice and sensor data". "We are delighted that Shah Talukder has agreed to join us," said Mr. MichaelKelly, the former banker and venture capitalist who spearheaded the mergerarrangements which gave ViaLogy a public quotation on the AIM last year. "At Cisco, Shah has built, managed, and mentored teams towards industryexcellence through product innovations and delivery of solutions and has createda start-up like culture which is reflected by the wide industry acceptance ofCisco IPICS." Mr. Kelly will remain on the board of ViaLogy PLC as a non-executive director. ViaLogy PLC's Chairman, Mr. Terry Bond, stated: "During the last five yearsViaLogy has successfully developed a range of network-centric, real-time signalprocessing technology platforms for sensor applications. We are now transformingViaLogy into a product and sales centric company. Shah Talukder is the idealperson to scale and develop the vision, strategy and focused execution needed tolead ViaLogy forward". For further information please contact: ViaLogy PLCTerry Bond, Chairman - ViaLogy PLC +44 (0)20 7869 7014 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 Seymour Pierce LimitedMark Percy / Liam O'Donoghue +44 (0)20 7107 8000 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defence andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th May 20187:00 amRNSYear-end Trading Update and £2.5m Fundraising
30th Apr 20184:00 pmRNSNotice of Trading Update
29th Mar 20187:00 amRNSPremaitha to attend industry conferences in APAC
26th Mar 20187:00 amRNSUpdate on UK patent infringement claim
16th Feb 20187:00 amRNSPremaitha secures market entry into Egypt
14th Feb 201810:25 amRNSHolding(s) in Company
12th Feb 20187:00 amRNSThermo Fisher - issue of warrants
6th Feb 20187:00 amRNSPremaitha to attend key conferences in Middle East
5th Feb 20187:00 amRNSPremaitha's IONA test approved for sale in Brazil
24th Jan 20187:00 amRNSUK High Court grants right to appeal
22nd Jan 20187:00 amRNSSecured loan facility agreement with Thermo Fisher
29th Dec 20177:00 amRNSHalf Year Results
11th Dec 20177:00 amRNSPremaitha secures four further laboratories in EU
1st Dec 20179:40 amRNSPremaitha CEO Wins Outstanding Contribution Award
27th Nov 20177:00 amRNSMiddle East laboratory network expansion
23rd Nov 20177:00 amRNSPremaitha signs new partner in East Asia
21st Nov 201710:47 amRNSLitigation First Instance Judgment
30th Oct 201710:08 amRNSGrant of Share Options
24th Oct 20173:45 pmRNSResult of AGM
24th Oct 20177:00 amRNSAGM Statement
13th Oct 20177:00 amRNSMiddle East Update
29th Sep 20177:04 amRNSFinal Results
29th Sep 20177:01 amRNSNotice of AGM
21st Sep 20174:05 pmRNSHolding(s) in Company
19th Sep 20177:00 amRNSPremaitha to offer NIPT in South Africa
7th Sep 20173:10 pmRNSFurther Patent Infringement Claims
29th Aug 20177:00 amRNSApproved for Good Manufacturing Process in Brazil
18th Jul 20172:02 pmRNSHolding(s) in Company
12th Jul 20177:00 amRNSInvestment Agreement Extension with Thermo Fisher
10th Jul 20177:00 amRNSPremaitha announces two laboratory hub contracts
3rd Jul 20177:00 amRNSLitigation Update
27th Jun 20177:00 amRNSHolding(s) in Company
16th Jun 20177:00 amRNSPremaitha launches Sage NIPT solution
5th Jun 20177:00 amRNSIndia Business Update
26th May 20177:00 amRNSIONA test validation on Thermo Fisher's Ion S5
19th May 20172:30 pmRNSPremaitha welcomes NIPT recommendation in France
16th May 20177:00 amRNSYear End Trading Update
12th May 20172:15 pmRNSUpdate Re. Swiss Customer
3rd Apr 20174:48 pmRNSHolding(s) in Company
31st Mar 20174:00 pmRNSSecond tranche of warrants issued to Thermo Fisher
17th Mar 20177:15 amRNSHardman Research: Expanding global distribution
13th Mar 20177:00 amRNSPremaitha to Attend International Medical Events
2nd Mar 201711:03 amRNSCompletion of Yourgene Acquisition
27th Feb 20177:00 amRNSCompletion of Acquisition
22nd Feb 20179:37 amRNSHolding(s) in Company
20th Feb 20177:00 amRNSMiddle East Business Update
16th Feb 20175:34 pmRNSHolding(s) in Company
15th Feb 20177:00 amRNSIssue of Equity
14th Feb 20179:32 amRNSHolding(s) in Company
13th Feb 20177:00 amRNSNew partnership with European diagnostics group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.